MECR
Enoyl-[acyl-carrier-protein] reductase, mitochondrial
Also known as: CGI-63, ETR1, FASN2B, MECR_HUMAN, NRBF1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BV79
- Gene
- MECR
- Ensembl
- ENSG00000116353
- Chromosome
- 1
- Canonical length
- 373 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is an oxidoreductase that catalyzes the last step in mitochondrial fatty acid synthesis. Defects in this gene are a cause of childhood-onset dystonia and optic atrophy. [provided by RefSeq, Mar 2017]
Canonical amino-acid sequenceUniProt
373 residues, UniProt reviewed canonical sequence.
>Q9BV79|MECR
1 MWVCSTLWRV RTPARQWRGL LPASGCHGPA ASSYSASAEP ARVRALVYGH HGDPAKVVEL
61 KNLELAAVRG SDVRVKMLAA PINPSDINMI QGNYGFLPEL PAVGGNEGVA QVVAVGSNVT
121 GLKPGDWVIP ANAGLGTWRT EAVFSEEALI QVPSDIPLQS AATLGVNPCT AYRMLMDFEQ
181 LQPGDSVIQN ASNSGVGQAV IQIAAALGLR TINVVRDRPD IQKLSDRLKS LGAEHVITEE
241 ELRRPEMKNF FKDMPQPRLA LNCVGGKSST ELLRQLARGG TMVTYGGMAK QPVVASVSLL
301 IFKDLKLRGF WLSQWKKDHS PDQFKELILT LCDLIRRGQL TAPACSQVPL QDYQSALEAS
361 MKPFISSKQI LTMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MECR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 9.2 nTPM
Expression across tissuesHPA
Tissue
- retina: 9.2 nTPM
- basal ganglia: 8.1 nTPM
- skeletal muscle: 7.8 nTPM
- cerebral cortex: 7.3 nTPM
- amygdala: 6.7 nTPM
- hippocampal formation: 6.7 nTPM
Single-cell type
- late spermatids: 184 nCPM
- rod photoreceptor cells: 148 nCPM
- migrating cytotrophoblasts: 87 nCPM
- cytotrophoblasts: 79 nCPM
- early spermatids: 74 nCPM
- adrenal medulla cells: 64 nCPM
Immune cell
- MAIT T-cell: 4 nTPM
- NK-cell: 3.1 nTPM
- plasmacytoid DC: 2.5 nTPM
- T-reg: 2.4 nTPM
- naive CD4 T-cell: 2.3 nTPM
- classical monocyte: 2.2 nTPM
Brain region
- cerebral cortex: 18 nTPM
- hippocampal formation: 18 nTPM
- pons: 16 nTPM
- white matter: 16 nTPM
- basal ganglia: 16 nTPM
- amygdala: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MECR.
Disease | AllUniProt
Conditions MECR is implicated in, by any mechanism.
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities (DYTOABG) MIM:617282
- Optic atrophy 16 (OPA16) MIM:620629
Disease | GeneticClinVar
31 pathogenic / likely-pathogenic of 353 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities
- Childhood Onset Dystonias
- Optic atrophy
- Optic atrophy 16
- Mitochondrial disease
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide biosynthetic process
- fatty acid biosynthetic process
- fatty acid metabolic process
- intracellular iron ion homeostasis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MECR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MECR as an antibody target. Whether an autoantibody or antibody against MECR could matter depends on whether native MECR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MECR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MECR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...